Ozempic has become one of the most talked-about diabetes medications in the world, especially as more adults ask about blood ...

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration has approved Afrezza for pediatric patients with diabetes ...

The FDA approved an inhaled needle-free insulin and a Delaware County teenager was part of the four year clinical trial.

Most patients in the control group received other GLP-1 drugs such as semaglutide, which Novo Nordisk sells for diabetes as ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. On one wall of endocrinologist Kevan Herold’s ...

Growing evidence suggests it takes a sustained viral infection in the right genetic environment to lead to type 1 diabetes.

Late-breaking Phase II data highlight enicepatide’s (CT-388) efficacy and safety, reinforcing its potential to deliver ...

Identifying children with early signs of type 1 diabetes makes a difference to their health. A new study suggests wider ...

Medicaid coverage is state-dependent. Some states provide CGMs with no cost-sharing, while others limit eligibility to Type 1 ...

Disease-modifying therapies for type 1 diabetes are beginning to move care beyond insulin replacement by targeting immune ...

Management of dry mouth through adequate hydration, sugar-free saliva stimulants, saliva substitutes, and fluoride ...

Cases of diabetes in Wales are climbing faster than projected, new NHS data has revealed. The number of people with diabetes ...